deltatrials
Unknown PHASE4 INTERVENTIONAL 3-arm NCT05920213

Efficacy of L-Ornithine L-Aspartate and Polyethylene Glycol in Cirrhotic Patients With Overt Hepatic Encephalopathy

HELP Trial: Efficacy of L-Ornithine L-Aspartate and Polyethylene Glycol in Cirrhotic Patients With Overt Hepatic Encephalopathy

Sponsor: Jinnah Postgraduate Medical Centre

Updated 5 times since 2023 Last updated: Jul 11, 2023 Started: Oct 31, 2023 Primary completion: Apr 30, 2024 Completion: Apr 30, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Hepatic Encephalopathy Stage 2 and Hepatic Encephalopathy Stage 3, this trial is ongoing. The trial is conducted by Jinnah Postgraduate Medical Centre and has accumulated 5 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jul 2023 – ~Aug 2023 · 31 days · monthly snapshot~Aug 2023 – ~Jul 2024 · 11 months · monthly snapshotNot Yet Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Aug 2025 · 11 months · monthly snapshotNot Yet Recruiting~Aug 2025 – present · 12 months · monthly snapshotUnknown

Change History

5 versions recorded
  1. Aug 2025 — Present [monthly]

    Unknown PHASE4

    Status: Not Yet RecruitingUnknown

  2. Sep 2024 — Aug 2025 [monthly]

    Not Yet Recruiting PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Not Yet Recruiting PHASE4

  4. Aug 2023 — Jul 2024 [monthly]

    Not Yet Recruiting PHASE4

  5. Jul 2023 — Aug 2023 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Jinnah Postgraduate Medical Centre
Data source: Jinnah Postgraduate Medical Centre

For direct contact, visit the study record on ClinicalTrials.gov .